Arctiin alleviates psoriasis-like dermatitis in association with gut microbiota remodeling and Akkermansia muciniphila enrichment

Introduction Psoriasis is a chronic recurrent inflammatory skin disease associated with gut microbiota dysbiosis. Arctiin (ARC), a plant-derived lignan, has anti-inflammatory and microbiota-modulating properties; however, its role in psoriasis remains unclear. Objective To investigate the protective effects of ARC against psoriasis-like dermatitis and the association between these effects and the gut microbiota. Methods Psoriasis-like dermatitis was induced in mice using topical imiquimod. ARC was administered prior to disease induction. Psoriasis-like inflammation was assessed by modified Psoriasis Area and Severity Index (mPASI) scoring, histopathology, immunofluorescence and RT–qPCR. The contribution of the gut microbiota was assessed using antibiotic treatment, fecal microbiota transplantation (FMT), and bacterial supplementation. The gut microbiota composition was analyzed by 16S rRNA gene sequencing. Results ARC markedly alleviated psoriasis-like inflammation, as evidenced by reduced mPASI scores, epidermal hyperplasia, immune cell infiltration and angiogenesis. ARC also decreased the expression of inflammatory mediators in psoriasis-like skin lesions. Antibiotic treatment attenuated the protective effects of ARC, whereas FMT from ARC-treated donors protected recipient mice. 16S rRNA sequencing revealed a reduced abundance of Akkermansia muciniphila (AKK) in psoriasis-like mice; the abundance was partially restored by ARC treatment. Supplementation with AKK partially recapitulated the protective effects of ARC, including the suppression of inflammatory cytokine expression and immune cell infiltration. Conclusion ARC alleviates psoriasis-like dermatitis through the modulation of the gut microbiota and the enrichment of AKK. These findings support a role for microbiota-associated mechanisms in ARC-mediated protection and highlight the potential of ARC as a microbiota-targeted therapeutic strategy for psoriasis.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-18
DOI
https://doi.org/10.3389/fimmu.2026.1954060
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Arctiin alleviates psoriasis-like dermatitis in association with gut microbiota remodeling and Akkermansia muciniphila enrichment

Wanchen Zhao, François Niyonsaba, Hideoki Ogawa, Alafate Abudouwanli et al.
3 links
Frontiers in Immunology
Psoriasis: Treatment and Pathogenesis
article

Arctiin alleviates psoriasis-like dermatitis in association with gut microbiota remodeling and Akkermansia muciniphila enrichment

Wanchen Zhao, François Niyonsaba, Hideoki Ogawa, Alafate Abudouwanli, Ko Okumura, Xinghua Gao, Yi Tan, Shan Wang, Quan Sun, Ge Peng, Mengyao Yang
article en

Abstract

Introduction Psoriasis is a chronic recurrent inflammatory skin disease associated with gut microbiota dysbiosis. Arctiin (ARC), a plant-derived lignan, has anti-inflammatory and microbiota-modulating properties; however, its role in psoriasis remains unclear. Objective To investigate the protective effects of ARC against psoriasis-like dermatitis and the association between these effects and the gut microbiota. Methods Psoriasis-like dermatitis was induced in mice using topical imiquimod. ARC was administered prior to disease induction. Psoriasis-like inflammation was assessed by modified Psoriasis Area and Severity Index (mPASI) scoring, histopathology, immunofluorescence and RT–qPCR. The contribution of the gut microbiota was assessed using antibiotic treatment, fecal microbiota transplantation (FMT), and bacterial supplementation. The gut microbiota composition was analyzed by 16S rRNA gene sequencing. Results ARC markedly alleviated psoriasis-like inflammation, as evidenced by reduced mPASI scores, epidermal hyperplasia, immune cell infiltration and angiogenesis. ARC also decreased the expression of inflammatory mediators in psoriasis-like skin lesions. Antibiotic treatment attenuated the protective effects of ARC, whereas FMT from ARC-treated donors protected recipient mice. 16S rRNA sequencing revealed a reduced abundance of Akkermansia muciniphila (AKK) in psoriasis-like mice; the abundance was partially restored by ARC treatment. Supplementation with AKK partially recapitulated the protective effects of ARC, including the suppression of inflammatory cytokine expression and immune cell infiltration. Conclusion ARC alleviates psoriasis-like dermatitis through the modulation of the gut microbiota and the enrichment of AKK. These findings support a role for microbiota-associated mechanisms in ARC-mediated protection and highlight the potential of ARC as a microbiota-targeted therapeutic strategy for psoriasis.

Frontiers in ImmunologyVol. 17
Juntendo University (JP), First Hospital of China Medical University (CN)
Ministry of Education, Culture, Sports, Science and Technology
Good health and well-being
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon